Paul Streck - 19 Dec 2022 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role: Chief Medical Officer
Signature: /s/ Jason Duncan, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 19 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 21 Dec 2022, 15:10:10 UTC
Next filing: 27 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALBO	Common Stock	Award	$0	+63,966		$0.000000	63,966	19 Dec 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs will vest as to 25% of the shares on December 19, 2023 with the remainder vesting in equal installments on the last day of 12 consecutive calendar quarters beginning on March 19, 2024 and ending on December 19, 2026, subject to the employee's continued service with the issuer through the applicable vesting dates.
F2	Represents 63,966 restricted stock units.

Content

Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs will vest as to 25% of the shares on December 19, 2023 with the remainder vesting in equal installments on the last day of 12 consecutive calendar quarters beginning on March 19, 2024 and ending on December 19, 2026, subject to the employee's continued service with the issuer through the applicable vesting dates.

Represents 63,966 restricted stock units.